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The use of gastric aspirates as a specimen of
choice in pulmonary tuberculosis diagnosis on
children from 0-11 years
A. Bulane ∗, A. Hoosen
University of the Free State, Bloemfontein, South
Africa
Background: Yearly about 9 million people develop tuberculo-
sis (TB), of which about 1 million cases occur in children less than
15 years. The diagnosis of tuberculous disease in children remains a
challenge. Childrenwith pulmonary tuberculosis aremostly unable
to produce sputum therefore gastric aspirates (GA) remain the
procedure of choice for microbiologic conﬁrmation of tuberculous
disease; however, yield is frequently low.
To evaluate the use of gastric aspirates as the specimen of choice
in diagnosis of pulmonary tuberculosis in children of 0-11 years of
age in NHLS Free state.
Methods & Materials: Retrospective study was conducted on
508 Gastric aspirates specimens submitted to NHLS from January
2012 toApril 2013 fromchildren≤11 years of age suspected of hav-
ing pulmonary tuberculosis. Of the 508, (45%) were females while
(55%) were males. The laboratory results (direct microscopy and
culture) were retrieved from NHLS DISA and reviewed
Results: Among the 508 children’s gastric aspirates specimen
submitted to NHLS for TB diagnosis; six specimens were positive
in direct microscopy (Auramin phenol staining) and eight had a
positive culture. Only two specimens were both culture and direct
microscopy positive. Among the 10 specimen that were positive
by culture, eight were drug susceptible while two were multidrug
resistant (MDR).
Conclusion: Data presented here indicates that, in this labo-
ratory, Gastric aspirates analysis did not signiﬁcantly contribute
in the laboratory diagnosis of pulmonary tuberculosis in children.
Therefore the use of special bicarbonate tube or cup was advised
in GA collection. If not available the laboratory must neutralize the
stomach acid with sodium bicarbonate within 30minutes as rec-
ommended in standard Laboratory Procedure in order to improve
the yield
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Development of puriﬁed recombinant antigens
for human African trypanosomes
S. Nzou
Nagasaki University - Kenya Medical Research
Institute Project, Nairobi, Kenya
Background: Human African Trypanosomiasis and Neglected
tropical diseases (NTDs) are some of the most common conditions
affecting people living in sub-Saharan Africa (SSA), and together
produce a burden of disease that may be equivalent to up to one-
half of SSA’s malaria disease burden and more than double that of
tuberculosis (Hotez et.,al 2009). The diagnosis of these diseases is
cumbersome, based on a high index of clinical suspicion. This study
entails developing recombinant proteins, determining the sensitiv-
ity and speciﬁcity of these antigens and evaluating their usability
in the determination of sero prevalence of the parasite and disease
burden to the community and nation as a whole using multiplex
technology.
Methods & Materials: cDNA for Trypanosoma brucei gambiense
antigens with tandem repeat were chemically synthesized by Inte-
grated DNA Technologies (IDT), and others were cloned from the
genomic DNA. The cDNAswere cloned into pET52b expression vec-
tor, then expressed in E.coli BL21(DE3). They were subjected to a
His-tag only or His-tag/StrepTagII double afﬁnity puriﬁcation. The
antigenswill be coupled ontomicrosphere beads and used formul-
tiplex analysis.
Results:Wehave successfully expressed andpuriﬁed14 recom-
binant antigens from inclusion body and soluble proteins; GM6,
Tbg6, MARP, FCaBP, 65kDa ISG, 64kDa ISG, RBP29, CBH11803,
CHB12270, CBH17169, CBH18122N terminus, CBH18122 tandem
repeat, I2, and I17. The protein expression was rated as good, ok
or low. 78.6% expressed good, 14.3% ok and 7.1% low respectively.
64.3% were expressed from soluble proteins while 35.7% were
expressed from inclusion body proteins. 28.6% of the antigenswere
found in both inclusion bodies and soluble proteins with 75% of
these antigens found in inclusion bodies.
Conclusion: Recombinant trypanosome antigens can be used
for human and zoonotic trypanosome disease surveillance. How-
ever, for practical development, pathogens and antigens of interest
must be selected and optimized. When optimized, the multiplex
technology will contribute to surveillance of trypanosome infec-
tions. Optimization of the puriﬁed antigens is now in progress to
determine the sensitivity and speciﬁcity of the recombinant anti-
gens. Highly speciﬁc and sensitive antigens will then be set for
surveillance program.
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